What is transfusion-related immunomodulation (TRIM) and its potential clinical implications?

Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

What is transfusion-related immunomodulation (TRIM) and its potential clinical implications?

Transfusion-related immunomodulation describes how components in transfused blood can transiently modify the recipient’s immune system. Donor leukocytes, cytokines, and other soluble mediators in blood products can dampen or alter immune responses, which may change a patient’s risk of infection and influence alloimmune reactions to donor antigens. Because these effects vary with factors like product type, leukoreduction, and the recipient’s condition, the clinical impact is not uniform, and TRIM may either increase infection risk or affect alloimmunization in different settings. This concept is distinct from hemovigilance (monitoring adverse events after transfusion), guidelines for a massive transfusion protocol, or the preparation of apheresis platelets.

Transfusion-related immunomodulation describes how components in transfused blood can transiently modify the recipient’s immune system. Donor leukocytes, cytokines, and other soluble mediators in blood products can dampen or alter immune responses, which may change a patient’s risk of infection and influence alloimmune reactions to donor antigens. Because these effects vary with factors like product type, leukoreduction, and the recipient’s condition, the clinical impact is not uniform, and TRIM may either increase infection risk or affect alloimmunization in different settings. This concept is distinct from hemovigilance (monitoring adverse events after transfusion), guidelines for a massive transfusion protocol, or the preparation of apheresis platelets.

More practice questions